Correlation Between Recursion Pharmaceuticals and GENERAL

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Recursion Pharmaceuticals and GENERAL at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Recursion Pharmaceuticals and GENERAL into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Recursion Pharmaceuticals and GENERAL ELEC CAP, you can compare the effects of market volatilities on Recursion Pharmaceuticals and GENERAL and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Recursion Pharmaceuticals with a short position of GENERAL. Check out your portfolio center. Please also check ongoing floating volatility patterns of Recursion Pharmaceuticals and GENERAL.

Diversification Opportunities for Recursion Pharmaceuticals and GENERAL

-0.06
  Correlation Coefficient

Good diversification

The 3 months correlation between Recursion and GENERAL is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and GENERAL ELEC CAP in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GENERAL ELEC CAP and Recursion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Recursion Pharmaceuticals are associated (or correlated) with GENERAL. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GENERAL ELEC CAP has no effect on the direction of Recursion Pharmaceuticals i.e., Recursion Pharmaceuticals and GENERAL go up and down completely randomly.

Pair Corralation between Recursion Pharmaceuticals and GENERAL

Given the investment horizon of 90 days Recursion Pharmaceuticals is expected to under-perform the GENERAL. In addition to that, Recursion Pharmaceuticals is 4.28 times more volatile than GENERAL ELEC CAP. It trades about -0.01 of its total potential returns per unit of risk. GENERAL ELEC CAP is currently generating about 0.02 per unit of volatility. If you would invest  9,944  in GENERAL ELEC CAP on September 12, 2024 and sell it today you would earn a total of  202.00  from holding GENERAL ELEC CAP or generate 2.03% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy39.77%
ValuesDaily Returns

Recursion Pharmaceuticals  vs.  GENERAL ELEC CAP

 Performance 
       Timeline  
Recursion Pharmaceuticals 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Recursion Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Recursion Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
GENERAL ELEC CAP 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GENERAL ELEC CAP has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, GENERAL is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Recursion Pharmaceuticals and GENERAL Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Recursion Pharmaceuticals and GENERAL

The main advantage of trading using opposite Recursion Pharmaceuticals and GENERAL positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Recursion Pharmaceuticals position performs unexpectedly, GENERAL can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GENERAL will offset losses from the drop in GENERAL's long position.
The idea behind Recursion Pharmaceuticals and GENERAL ELEC CAP pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years